img

Global Seasonal Influenza Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Seasonal Influenza Vaccines Market Research Report 2024

Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.
According to Mr Accuracy reports new survey, global Seasonal Influenza Vaccines market is projected to reach US$ 11150 million in 2029, increasing from US$ 6969 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Seasonal Influenza Vaccines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Seasonal Influenza Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG
AstraZeneca
EMERGEX VACCINES
SINOVAC
Merck & Co., Inc.
Pfizer Inc
Viatris Inc.
Vaxess Technologies Inc
OSIVAX
CSL Limited
EMERGENT
Segment by Type
Type A (H1N1)
Type A (H3N2)
Type B

Segment by Application


Pediatrics
Adolescence
Adults
Elderly

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Seasonal Influenza Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Seasonal Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Seasonal Influenza Vaccines
1.2 Seasonal Influenza Vaccines Segment by Type
1.2.1 Global Seasonal Influenza Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Seasonal Influenza Vaccines Segment by Application
1.3.1 Global Seasonal Influenza Vaccines Market Value by Application: (2024-2034)
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Seasonal Influenza Vaccines Revenue 2018-2029
1.4.2 Global Seasonal Influenza Vaccines Sales 2018-2029
1.4.3 Global Seasonal Influenza Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Seasonal Influenza Vaccines Market Competition by Manufacturers
2.1 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Seasonal Influenza Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
2.7 Seasonal Influenza Vaccines Market Competitive Situation and Trends
2.7.1 Seasonal Influenza Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Seasonal Influenza Vaccines Players Market Share by Revenue
2.7.3 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Seasonal Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Seasonal Influenza Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Seasonal Influenza Vaccines Global Seasonal Influenza Vaccines Sales by Region: 2018-2029
3.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2018-2024
3.2.2 Global Seasonal Influenza Vaccines Sales by Region: 2024-2029
3.3 Global Seasonal Influenza Vaccines Global Seasonal Influenza Vaccines Revenue by Region: 2018-2029
3.3.1 Global Seasonal Influenza Vaccines Revenue by Region: 2018-2024
3.3.2 Global Seasonal Influenza Vaccines Revenue by Region: 2024-2029
3.4 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.4.3 North America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.5.3 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Seasonal Influenza Vaccines Sales by Type (2018-2029)
4.1.1 Global Seasonal Influenza Vaccines Sales by Type (2018-2024)
4.1.2 Global Seasonal Influenza Vaccines Sales by Type (2024-2029)
4.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Seasonal Influenza Vaccines Revenue by Type (2018-2029)
4.2.1 Global Seasonal Influenza Vaccines Revenue by Type (2018-2024)
4.2.2 Global Seasonal Influenza Vaccines Revenue by Type (2024-2029)
4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Seasonal Influenza Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Seasonal Influenza Vaccines Sales by Application (2018-2029)
5.1.1 Global Seasonal Influenza Vaccines Sales by Application (2018-2024)
5.1.2 Global Seasonal Influenza Vaccines Sales by Application (2024-2029)
5.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Seasonal Influenza Vaccines Revenue by Application (2018-2029)
5.2.1 Global Seasonal Influenza Vaccines Revenue by Application (2018-2024)
5.2.2 Global Seasonal Influenza Vaccines Revenue by Application (2024-2029)
5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Seasonal Influenza Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Corporation Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Sinovac Biotech Ltd
6.2.1 Sinovac Biotech Ltd Corporation Information
6.2.2 Sinovac Biotech Ltd Description and Business Overview
6.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
6.2.5 Sinovac Biotech Ltd Recent Developments/Updates
6.3 Changsheng Bio-Technology
6.3.1 Changsheng Bio-Technology Corporation Information
6.3.2 Changsheng Bio-Technology Description and Business Overview
6.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
6.3.5 Changsheng Bio-Technology Recent Developments/Updates
6.4 Ccbio SA
6.4.1 Ccbio SA Corporation Information
6.4.2 Ccbio SA Description and Business Overview
6.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
6.4.5 Ccbio SA Recent Developments/Updates
6.5 Aleph Biomedical
6.5.1 Aleph Biomedical Corporation Information
6.5.2 Aleph Biomedical Description and Business Overview
6.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
6.5.5 Aleph Biomedical Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
6.6.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
6.6.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
6.6.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
6.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
6.8 Dalian Hissen Bio-pharm
6.8.1 Dalian Hissen Bio-pharm Corporation Information
6.8.2 Dalian Hissen Bio-pharm Description and Business Overview
6.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
6.8.5 Dalian Hissen Bio-pharm Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Novartis International AG
6.10.1 Novartis International AG Corporation Information
6.10.2 Novartis International AG Description and Business Overview
6.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
6.10.5 Novartis International AG Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Seasonal Influenza Vaccines Description and Business Overview
6.11.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 EMERGEX VACCINES
6.12.1 EMERGEX VACCINES Corporation Information
6.12.2 EMERGEX VACCINES Seasonal Influenza Vaccines Description and Business Overview
6.12.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
6.12.5 EMERGEX VACCINES Recent Developments/Updates
6.13 SINOVAC
6.13.1 SINOVAC Corporation Information
6.13.2 SINOVAC Seasonal Influenza Vaccines Description and Business Overview
6.13.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
6.13.5 SINOVAC Recent Developments/Updates
6.14 Merck & Co., Inc.
6.14.1 Merck & Co., Inc. Corporation Information
6.14.2 Merck & Co., Inc. Seasonal Influenza Vaccines Description and Business Overview
6.14.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
6.14.5 Merck & Co., Inc. Recent Developments/Updates
6.15 Pfizer Inc
6.15.1 Pfizer Inc Corporation Information
6.15.2 Pfizer Inc Seasonal Influenza Vaccines Description and Business Overview
6.15.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
6.15.5 Pfizer Inc Recent Developments/Updates
6.16 Viatris Inc.
6.16.1 Viatris Inc. Corporation Information
6.16.2 Viatris Inc. Seasonal Influenza Vaccines Description and Business Overview
6.16.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
6.16.5 Viatris Inc. Recent Developments/Updates
6.17 Vaxess Technologies Inc
6.17.1 Vaxess Technologies Inc Corporation Information
6.17.2 Vaxess Technologies Inc Seasonal Influenza Vaccines Description and Business Overview
6.17.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
6.17.5 Vaxess Technologies Inc Recent Developments/Updates
6.18 OSIVAX
6.18.1 OSIVAX Corporation Information
6.18.2 OSIVAX Seasonal Influenza Vaccines Description and Business Overview
6.18.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.18.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
6.18.5 OSIVAX Recent Developments/Updates
6.19 CSL Limited
6.19.1 CSL Limited Corporation Information
6.19.2 CSL Limited Seasonal Influenza Vaccines Description and Business Overview
6.19.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.19.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
6.19.5 CSL Limited Recent Developments/Updates
6.20 EMERGENT
6.20.1 EMERGENT Corporation Information
6.20.2 EMERGENT Seasonal Influenza Vaccines Description and Business Overview
6.20.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.20.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
6.20.5 EMERGENT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Seasonal Influenza Vaccines Industry Chain Analysis
7.2 Seasonal Influenza Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Seasonal Influenza Vaccines Production Mode & Process
7.4 Seasonal Influenza Vaccines Sales and Marketing
7.4.1 Seasonal Influenza Vaccines Sales Channels
7.4.2 Seasonal Influenza Vaccines Distributors
7.5 Seasonal Influenza Vaccines Customers
8 Seasonal Influenza Vaccines Market Dynamics
8.1 Seasonal Influenza Vaccines Industry Trends
8.2 Seasonal Influenza Vaccines Market Drivers
8.3 Seasonal Influenza Vaccines Market Challenges
8.4 Seasonal Influenza Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Seasonal Influenza Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Seasonal Influenza Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Seasonal Influenza Vaccines Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Seasonal Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Seasonal Influenza Vaccines Sales by Region (2018-2024) & (K Units)
Table 18. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Seasonal Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 27. North America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 32. Europe Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2018-2024)
Table 51. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Seasonal Influenza Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2018-2024)
Table 59. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2024-2029)
Table 60. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2018-2024)
Table 61. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Seasonal Influenza Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2018-2024)
Table 69. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2024-2029)
Table 70. GlaxoSmithKline plc Corporation Information
Table 71. GlaxoSmithKline plc Description and Business Overview
Table 72. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. GlaxoSmithKline plc Seasonal Influenza Vaccines Product
Table 74. GlaxoSmithKline plc Recent Developments/Updates
Table 75. Sinovac Biotech Ltd Corporation Information
Table 76. Sinovac Biotech Ltd Description and Business Overview
Table 77. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product
Table 79. Sinovac Biotech Ltd Recent Developments/Updates
Table 80. Changsheng Bio-Technology Corporation Information
Table 81. Changsheng Bio-Technology Description and Business Overview
Table 82. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Changsheng Bio-Technology Seasonal Influenza Vaccines Product
Table 84. Changsheng Bio-Technology Recent Developments/Updates
Table 85. Ccbio SA Corporation Information
Table 86. Ccbio SA Description and Business Overview
Table 87. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Ccbio SA Seasonal Influenza Vaccines Product
Table 89. Ccbio SA Recent Developments/Updates
Table 90. Aleph Biomedical Corporation Information
Table 91. Aleph Biomedical Description and Business Overview
Table 92. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Aleph Biomedical Seasonal Influenza Vaccines Product
Table 94. Aleph Biomedical Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Sanofi Seasonal Influenza Vaccines Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 101. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
Table 102. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product
Table 104. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
Table 105. Dalian Hissen Bio-pharm Corporation Information
Table 106. Dalian Hissen Bio-pharm Description and Business Overview
Table 107. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product
Table 109. Dalian Hissen Bio-pharm Recent Developments/Updates
Table 110. Abbott Laboratories Corporation Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Abbott Laboratories Seasonal Influenza Vaccines Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Novartis International AG Corporation Information
Table 116. Novartis International AG Description and Business Overview
Table 117. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Novartis International AG Seasonal Influenza Vaccines Product
Table 119. Novartis International AG Recent Developments/Updates
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. AstraZeneca Seasonal Influenza Vaccines Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. EMERGEX VACCINES Corporation Information
Table 126. EMERGEX VACCINES Description and Business Overview
Table 127. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. EMERGEX VACCINES Seasonal Influenza Vaccines Product
Table 129. EMERGEX VACCINES Recent Developments/Updates
Table 130. SINOVAC Corporation Information
Table 131. SINOVAC Description and Business Overview
Table 132. SINOVAC Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. SINOVAC Seasonal Influenza Vaccines Product
Table 134. SINOVAC Recent Developments/Updates
Table 135. Merck & Co., Inc. Corporation Information
Table 136. Merck & Co., Inc. Description and Business Overview
Table 137. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Merck & Co., Inc. Seasonal Influenza Vaccines Product
Table 139. Merck & Co., Inc. Recent Developments/Updates
Table 140. Pfizer Inc Corporation Information
Table 141. Pfizer Inc Description and Business Overview
Table 142. Pfizer Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Pfizer Inc Seasonal Influenza Vaccines Product
Table 144. Pfizer Inc Recent Developments/Updates
Table 145. Viatris Inc. Corporation Information
Table 146. Viatris Inc. Description and Business Overview
Table 147. Viatris Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Viatris Inc. Seasonal Influenza Vaccines Product
Table 149. Viatris Inc. Recent Developments/Updates
Table 150. Vaxess Technologies Inc Corporation Information
Table 151. Vaxess Technologies Inc Description and Business Overview
Table 152. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Vaxess Technologies Inc Seasonal Influenza Vaccines Product
Table 154. Vaxess Technologies Inc Recent Developments/Updates
Table 155. OSIVAX Corporation Information
Table 156. OSIVAX Description and Business Overview
Table 157. OSIVAX Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. OSIVAX Seasonal Influenza Vaccines Product
Table 159. OSIVAX Recent Developments/Updates
Table 160. CSL Limited Corporation Information
Table 161. CSL Limited Description and Business Overview
Table 162. CSL Limited Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. CSL Limited Seasonal Influenza Vaccines Product
Table 164. CSL Limited Recent Developments/Updates
Table 165. EMERGENT Corporation Information
Table 166. EMERGENT Description and Business Overview
Table 167. EMERGENT Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. EMERGENT Seasonal Influenza Vaccines Product
Table 169. EMERGENT Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Seasonal Influenza Vaccines Distributors List
Table 173. Seasonal Influenza Vaccines Customers List
Table 174. Seasonal Influenza Vaccines Market Trends
Table 175. Seasonal Influenza Vaccines Market Drivers
Table 176. Seasonal Influenza Vaccines Market Challenges
Table 177. Seasonal Influenza Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Seasonal Influenza Vaccines
Figure 2. Global Seasonal Influenza Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Type A (H1N1) Product Picture
Figure 5. Type A (H3N2) Product Picture
Figure 6. Type B Product Picture
Figure 7. Global Seasonal Influenza Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 9. Pediatrics
Figure 10. Adolescence
Figure 11. Adults
Figure 12. Elderly
Figure 13. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Seasonal Influenza Vaccines Market Size (2018-2029) & (US$ Million)
Figure 15. Global Seasonal Influenza Vaccines Sales (2018-2029) & (K Units)
Figure 16. Global Seasonal Influenza Vaccines Average Price (USD/Unit) & (2018-2029)
Figure 17. Seasonal Influenza Vaccines Report Years Considered
Figure 18. Seasonal Influenza Vaccines Sales Share by Manufacturers in 2022
Figure 19. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Seasonal Influenza Vaccines Players: Market Share by Revenue in 2022
Figure 21. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Seasonal Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 28. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 29. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2029)
Figure 36. China Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Seasonal Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 47. Latin America Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Seasonal Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Seasonal Influenza Vaccines by Type (2018-2029)
Figure 57. Global Revenue Market Share of Seasonal Influenza Vaccines by Type (2018-2029)
Figure 58. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Seasonal Influenza Vaccines by Application (2018-2029)
Figure 60. Global Revenue Market Share of Seasonal Influenza Vaccines by Application (2018-2029)
Figure 61. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2018-2029)
Figure 62. Seasonal Influenza Vaccines Value Chain
Figure 63. Seasonal Influenza Vaccines Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries